drugset / Trial / NCT05975684

Baclofen for Children With Rumination Syndrome

NCT05975684

Phase 3 Completed 50 enrolled Nationwide Children's Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this clinical trial is to learn about baclofen in pediatric patients with rumination syndrome. The main question it aims to answer is whether baclofen is effective in treating children with rumination syndrome. Participants will be asked to take baclofen or placebo for 4 weeks and fill out surveys regarding symptoms.

Timeline

Start
2023-01-31
Primary completion
2024-07-31
Completion
2025-01-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Baclofen Small molecule 0.5 mg/kg

Indications